Canlyniadau Chwilio - Gebregiworgis, Teklab

Application of NMR Metabolomics to Search for Human Disease Biomarkers gan Gebregiworgis, Teklab, Powers, Robert

Cael y testun llawn Cael y testun llawn

Insights into Gemcitabine Resistance and the Potential for Therapeutic Monitoring gan Gebregiworgis, Teklab, Bhinderwala, Fatema, Purohit, Vinee, Chaika, Nina V., Singh, Pankaj K., Powers, Robert

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica gan Gebregiworgis, Teklab, Nielsen, Helle H., Massilamany, Chandirasegaran, Gangaplara, Arunakumar, Reddy, Jay, Illes, Zsolt, Powers, Robert

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine–dependent interface: a model for KRAS oligomerization gan Lee, Ki-Young, Enomoto, Masahiro, Gebregiworgis, Teklab, Gasmi-Seabrook, Geneviève M. C., Ikura, Mitsuhiko, Marshall, Christopher B.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The potential of urinary metabolites for diagnosing multiple sclerosis gan Gebregiworgis, Teklab, Massilamany, Chandirasegaran, Gangaplara, Arunakumar, Thulasingam, Sivasubramani, Kolli, Venkata, Werth, Mark T., Dodds, Eric D., Steffen, David, Reddy, Jay, Powers, Robert

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells gan Gebregiworgis, Teklab, Purohit, Vinee, Shukla, Surendra K., Tadros, Saber, Chaika, Nina V., Abrego, Jaime, Mulder, Scott E., Gunda, Venugopal, Singh, Pankaj K., Powers, Robert

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia gan Shukla, Surendra K, Gebregiworgis, Teklab, Purohit, Vinee, Chaika, Nina V, Gunda, Venugopal, Radhakrishnan, Prakash, Mehla, Kamiya, Pipinos, Iraklis I, Powers, Robert, Yu, Fang, Singh, Pankaj K

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia gan Shukla, Surendra K, Gebregiworgis, Teklab, Purohit, Vinee, Chaika, Nina V, Gunda, Venugopal, Radhakrishnan, Prakash, Mehla, Kamiya, Pipinos, Iraklis I, Powers, Robert, Yu, Fang, Singh, Pankaj K

Cael y testun llawn Cael y testun llawn

MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer gan Chaika, Nina V., Gebregiworgis, Teklab, Lewallen, Michelle E., Purohit, Vinee, Radhakrishnan, Prakash, Liu, Xiang, Zhang, Bo, Mehla, Kamiya, Brown, Roger B., Caffrey, Thomas, Yu, Fang, Johnson, Keith R., Powers, Robert, Hollingsworth, Michael A., Singh, Pankaj K.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation gan Kano, Yoshihito, Gebregiworgis, Teklab, Marshall, Christopher B., Radulovich, Nikolina, Poon, Betty P. K., St-Germain, Jonathan, Cook, Jonathan D., Valencia-Sama, Ivette, Grant, Benjamin M. M., Herrera, Silvia Gabriela, Miao, Jinmin, Raught, Brian, Irwin, Meredith S., Lee, Jeffrey E., Yeh, Jen Jen, Zhang, Zhong-Yin, Tsao, Ming-Sound, Ikura, Mitsuhiko, Ohh, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors gan Gebregiworgis, Teklab, Kano, Yoshihito, St-Germain, Jonathan, Radulovich, Nikolina, Udaskin, Molly L., Mentes, Ahmet, Huang, Richard, Poon, Betty P. K., He, Wenguang, Valencia-Sama, Ivette, Robinson, Claire M., Huestis, Melissa, Miao, Jinmin, Yeh, Jen Jen, Zhang, Zhong-Yin, Irwin, Meredith S., Lee, Jeffrey E., Tsao, Ming-Sound, Raught, Brian, Marshall, Christopher B., Ohh, Michael, Ikura, Mitsuhiko

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Regulation of GTPase function by autophosphorylation gan Johnson, Christian W., Seo, Hyuk-Soo, Terrell, Elizabeth M., Yang, Moon-Hee, KleinJan, Fenneke, Gebregiworgis, Teklab, Gasmi-Seabrook, Genevieve M.C., Geffken, Ezekiel A., Lakhani, Jimit, Song, Kijun, Bashyal, Puspalata, Popow, Olesja, Paulo, Joao A., Liu, Andrea, Mattos, Carla, Marshall, Christopher B., Ikura, Mitsuhiko, Morrison, Deborah K., Dhe-Paganon, Sirano, Haigis, Kevin M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer gan Shukla, Surendra K., Purohit, Vinee, Mehla, Kamiya, Gunda, Venugopal, Chaika, Nina V., Vernucci, Enza, King, Ryan J., Abrego, Jaime, Goode, Gennifer D., Dasgupta, Aneesha, Illies, Alysha L, Gebregiworgis, Teklab, Dai, Bingbing, Augustine, Jithesh J., Murthy, Divya, Attri, Kuldeep S., Mashadova, Oksana, Grandgenett, Paul M, Powers, Robert, Ly, Quan P., Lazenby, Audrey J., Grem, Jean L, Yu, Fang, Matés, José M., Asara, John M., Kim, Jung-whan, Hankins, Jordan H, Weekes, Colin, Hollingsworth, Michael A., Sarkova, Natalie J., Sasson, Aaron R, Fleming, Jason B., Oliveto, Jennifer M, Lyssiotis, Costas A., Cantley, Lewis C., Berim, Lyudmyla, Singh, Pankaj K.

Cael y testun llawn Cael y testun llawn Cael y testun llawn